NCT07742059Completed
My Hospital Buddy Ida: AR-CBT for Children With Cancer
Augmented Reality-Supported Cognitive Behavioral Therapy for Children With Cancer: A Three-Arm Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if an augmented reality (AR) mobile app-based cognitive behavioral therapy (CBT) program can help children aged 6 to 12 years who are being treated for cancer cope with treatment-related distress and improve their quality of life. The main questions it aims to answer are: * Does an AR-supported CBT app improve health-related quality of life compared with the same CBT content delivered on paper, and compared with usual care? * Does the AR-CBT app improve resilience, emotional and behavioral functioning, anxiety, and treatment-related symptoms such as nausea and fatigue, compared with the other two groups? Researchers will compare three groups: an AR-CBT group using a smartphone/tablet app called "My Hospital Buddy Ida," a Standard CBT group receiving the same content through a printed workbook, and a usual care control group, to see if the AR app leads to greater improvement in quality of life and related outcomes. Participants will: * Be randomly assigned to one of the three groups * Complete a 12-module, 9-session CBT and Child Life program (AR-CBT and Standard CBT groups) or continue usual hospital care (control group) * Complete questionnaires about quality of life, resilience, emotional and behavioral symptoms, anxiety, and treatment-related symptoms before and after the program (approximately 9 to 12 weeks later)
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 114 (actual)
- First submitted
- 21 Jul 2026
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Koç University
- Diseases
- Childhood cancers
- NCT number
- NCT07742059
What you commit to
- Study type: Interventional
- Participants enrolled: 114
- From 1 Apr 2024 to the primary completion date, 1 Feb 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic illness other than cancer
- Diagnosed brain disease
- Epilepsy
- Severe neurodevelopmental or neurological disorder
- History of motion sickness
- Sensory or cognitive impairment precluding use of the AR application
Other
- Clouded consciousness or delirium
Who the study is looking for
- Diagnosis of any childhood cancer
- Currently within the first 4 months of chemotherapy treatment
- Has completed at least 1 prior chemotherapy cycle
- Sufficient Turkish language ability to complete study measures
- Presence of a literate caregiver able to provide consent and assist with study procedures
Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Akdeniz Universitesi Hastanesi Coordinator of this site? Confirm its status | Antalya | Turkey (Türkiye) | Unknown status |
| Koc University Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
| Istanbul Universitesi Onkoloji Enstitusu Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
| Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
Related publications
- Augmented Reality-Supported Cognitive Behavioral Therapy for Children With Cancer: A Multicenter, Three-Arm Randomized Controlled Trial.Pediatr Blood Cancer · 2026 · PMID 42813391
This page is information, not medical advice. Discuss any trial with your doctor.